MAGLi 432 is a potent, highly selective, non-covalent, reversible (MAGL) inhibitor that binds with high affinity to the MAGL active site, with IC50 values of 4.2 nM (human enzyme) and 3.1 nM (mouse enzyme), MAGLi 432 can be used to study neurological disorders such as chronic inflammation, multiple sclerosis, blood-brain barrier dysfunction, Alzheimers disease and Parkinsons disease.
Molekulargewicht:
463.8
CAS Nummer:
[2361575-20-2]
Formel:
C22H24BrClN2O2
Target-Kategorie:
Others|||MAGL
T62937
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten